Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Roch Houot , Emmanuel Bachy , Guillaume Cartron , François-Xavier Gros , Franck Morschhauser , Lucie Oberic , Thomas Gastinne , Pierre Feugier , Rémy Duléry , Catherine Thieblemont , Magalie Joris , Fabrice Jardin , Sylvain Choquet , Olivier Casasnovas , Gabriel Brisou , Morgane Cheminant , Jacques-Olivier Bay , Francisco Llamas Gutierrez , Cédric Menard , Karin Tarte , Marie-Hélène Delfau , Cédric Portugues , Emmanuel Itti , Xavier Palard-Novello , Paul Blanc-Durand , Yassine Al Tabaa , Clément Bailly , Camille Laurent , François Lemonnier Nature medicine（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
